Citation Impact
Citing Papers
Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma
2009
Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 : A Report by MSKCC and the KIRC TCGA Research Network
2013
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Nitric Oxide Inactivates the Retinoblastoma Pathway in Chronic Inflammation
2007
The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma
2010
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
The NADPH Oxidase Subunit p22 Inhibits the Function of the Tumor Suppressor Protein Tuberin
2010
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Degradation of proteins by PROTACs and other strategies
2019
ESUR prostate MR guidelines 2012
2012 Standout
Molecular mechanisms and clinical management of cancer bone metastasis
2020
Hallmarks of Cancer: The Next Generation
2011 Standout
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness
2012
The role of m6A RNA methylation in human cancer
2019 Standout
Tumor Engineering: Orthotopic Cancer Models in Mice Using Cell-Loaded, Injectable, Cross-Linked Hyaluronan-Derived Hydrogels
2007
A Proposal for Reclassification of the Fuhrman Grading System in Patients with Clear Cell Renal Cell Carcinoma
2009
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
2005
Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a–T1b Renal Mass and Normal Preoperative Renal Function
2014
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Genetic variation inCLDN1and susceptibility to hepatitis C virus infection
2009 StandoutNobel
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations
2002
Reproducibility Studies on Arteriolar Hyaline Thickening Scoring in Calcineurin Inhibitor-Treated Renal Allograft Recipients
2006
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Long-term results of standard procedures in urology: the ileal neobladder
2006
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy
2008
Nomograms in oncology: more than meets the eye
2015 Standout
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Prostate Cancer: Sextant Localization with MR Imaging, MR Spectroscopy, and11C-Choline PET/CT
2007
Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
2012
Imaging angiogenesis of genitourinary tumors
2010
Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34
2005
Angiomyolipoma with Minimal Fat: Can It Be Differentiated from Clear Cell Renal Cell Carcinoma by Using Standard MR Techniques?
2012
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity
2007 StandoutNobel
Osteoarthritis
2015 Standout
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
2008
Skeletal remodeling in health and disease
2007 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
2010 Standout
Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference
2009 StandoutNobel
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Clinical benefits of a multivariate prediction model for bladder cancer
2009
Renal Cell Carcinoma: Dynamic Contrast-enhanced MR Imaging for Differentiation of Tumor Subtypes—Correlation with Pathologic Findings
2009
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
2013
Introduction to small renal tumours and prognostic indicators
2016
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Expression and Signaling of Parathyroid Hormone-Related Protein in Cultured Podocytes
2001
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
Pretreatment Evaluation of Prostate Cancer: Role of MR Imaging and1H MR Spectroscopy
2004
Hyaluronan synthesis and degradation in cartilage and bone
2007
A Review of Integrated Staging Systems for Renal Cell Carcinoma
2012
PROTAC targeted protein degraders: the past is prologue
2022 Standout
VHL, the story of a tumour suppressor gene
2014
A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma
2009
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
2020 Standout
The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network
2019
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
2011
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
2013
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population‐based study
2008
Mitochondrial disorders in renal tumors
2006
Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?
2006
Interstitial photodynamic therapy for prostate cancer: a developing modality
2004
A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma
2008
Hypoxia-inducible factor 1 and breast cancer metastasis
2015 StandoutNobel
Renal cell carcinoma
2017 Standout
Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study
2016
ROS signalling in the biology of cancer
2017 Standout
Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping
2003
HIF-1 mediates the Warburg effect in clear cell renal carcinoma
2007 StandoutNobel
Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions
2007
Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway
2017 StandoutNobel
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Nephron‐sparing surgery
2007
Cell Biology of the Glomerular Podocyte
2003 Standout
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Trends in biomarker research for cancer detection
2001
The Chromophobe Tumor Grading System is the Preferred Grading Scheme for Chromophobe Renal Cell Carcinoma
2011
Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
2013
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carcinoma: Results From a Large, Single Institution Cohort
2011
Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor
2007
SQUID-Detected Magnetic Resonance Imaging in Microtesla Fields
2007 StandoutNobel
Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors
2007 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Works of Hervé Lang being referenced
Prognostic Value of Microscopic Venous Invasion in Renal Cell Carcinoma: Long-Term Follow-Up
2004
Partial Versus Radical Nephrectomy in Patients With Adverse Clinical or Pathologic Characteristics
2009
MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses
2006
Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma
2004
Relationship between Age at Diagnosis and Clinicopathologic Features of Renal Cell Carcinoma
2006
The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth
2009
Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo
2005
von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR
2008
Prognostic Value of Multifocality on Progression and Survival in Localized Renal Cell Carcinoma
2004
An FGFR 3/ MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
2018
The Phosphoinositide 3-Kinase/Akt Pathway: A New Target in Human Renal Cell Carcinoma Therapy
2006
Targeting FAK scaffold functions inhibits human renal cell carcinoma growth
2015
Parathyroid Hormone-Related Protein in Rat Penis: Expression, Localization, and Effect on Cavernosal Pressure1
1999
Comparative Sensitivities of Functional MRI Sequences in Detection of Local Recurrence of Prostate Carcinoma After Radical Prostatectomy or External-Beam Radiotherapy
2013
Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram
2007
Tumeurs du Rein
2007
A New Staging System for Locally Advanced (pT3–4) Renal Cell Carcinoma: A Multicenter European Study Including 2,000 Patients
2007
Parathyroid Hormone-Related Protein Is an Essential Growth Factor for Human Clear Cell Renal Carcinoma and a Target for the von Hippel-Lindau Tumor Suppressor Gene
2004
ORTHOTOPIC ILEAL NEOBLADDER RECONSTRUCTION IN PATIENTS WITH BLADDER CANCER FOLLOWING RENAL TRANSPLANTATION
2005
Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.
2000
Prognostic Value of Microvascular Invasion in Predicting the Cancer Specific Survival and Risk of Metastatic Disease in Renal Cell Carcinoma: A Multicenter Investigation
2011
Contrast Enhances Color Doppler Endorectal Sonography of Prostate: Efficiency for Detecting Peripheral Zone Tumors and Role for Biopsy Procedure
2003